Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Jun;82(2):501–508. doi: 10.1111/j.1476-5381.1984.tb10786.x

Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites?

E Krstew, G A McPherson, E Malta, P Molenaar, C Raper
PMCID: PMC1987030  PMID: 6145474

Abstract

Ro 03-7894 (0.6 mM) produced a non-parallel shift to the right of dose-response curves to (-)-isoprenaline in K+ depolarized uterine preparations from the guinea-pig. The displacement of the curves was readily reversed by washing. A rightward shift of similar magnitude was also produced by Ro 03-7894 in transmurally stimulated ileal preparations. The relaxant effects of fenoterol in carbachol-contracted guinea-pig tracheal preparations (in the presence of 2 microM atenolol) were not altered by 0.6 mM Ro 03-7894. In the three tissues there was no evidence of a reduction in the maximal inhibitory response to the agonists. In uterine and tracheal preparations, Ro 03-7894 (0.6 mM) depressed contractile responses to exogenous calcium. The depression of responses was enhanced after washout of Ro 03-7894 for 80 min. Contractile responses of ileal preparations to transmural stimulation were also depressed by Ro 03-7894. Concentration-effect curves for the positive inotropic effects of (-)-isoprenaline in guinea-pig left atrial preparations were markedly shifted to the right and the maximum response depressed by 0.6 mM Ro 03-7894. Although the rightward shift of the curves was fully reversed during the 120 min washout period, the maximal responses remained depressed. In similar experiments, Ro 03-7894 produced a washout-resistant depression of inotropic responses to histamine and calcium. The results of radioligand binding studies in left atria using (-)-[125I]-iodocyanopindolol indicated that, when compared to the untreated atria, there was no reduction in the maximal density of binding sites 120 min after washout of 0.6 mM Ro 03-7894.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker S. P., Posner P. The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes. Life Sci. 1983 Aug 1;33(5):459–466. doi: 10.1016/0024-3205(83)90795-6. [DOI] [PubMed] [Google Scholar]
  2. Broadley K. J., Nicholson C. D. Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist. Br J Pharmacol. 1981 Apr;72(4):635–643. doi: 10.1111/j.1476-5381.1981.tb09143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hoyer D., Engel G., Berthold R. Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):319–329. doi: 10.1007/BF00501172. [DOI] [PubMed] [Google Scholar]
  4. Krstew E., Malta E., Raper C. Comparison of guinea pig uterine and rat vas deferens preparations for assessment of beta 2-adrenoceptor-mediated activity. J Pharmacol Methods. 1982 Dec;8(4):279–289. doi: 10.1016/0160-5402(82)90045-6. [DOI] [PubMed] [Google Scholar]
  5. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  6. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  7. Mylecharane E. J., Raper C. Beta-receptor blocking and cardiodepressant actions of 2-nitrilophenoxypropanolamines. Eur J Pharmacol. 1971 Sep;16(1):14–20. doi: 10.1016/0014-2999(71)90051-3. [DOI] [PubMed] [Google Scholar]
  8. Mylecharane E. J., Raper C. Influence of N-alkyl substitution on antagonism at 1 - and 2 -receptor sites. Eur J Pharmacol. 1973 Mar;21(3):375–378. doi: 10.1016/0014-2999(73)90142-8. [DOI] [PubMed] [Google Scholar]
  9. Nicholson C. D., Broadley K. J. Irreversible beta-adrenoceptor blockade of atrial rate and tension responses. Eur J Pharmacol. 1978 Dec 1;52(3-4):259–269. doi: 10.1016/0014-2999(78)90278-9. [DOI] [PubMed] [Google Scholar]
  10. Rankin A., Broadley K. J. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques. Biochem Pharmacol. 1982 Apr 1;31(7):1325–1332. doi: 10.1016/0006-2952(82)90024-7. [DOI] [PubMed] [Google Scholar]
  11. Spedding M. Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups. Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):234–240. doi: 10.1007/BF00500485. [DOI] [PubMed] [Google Scholar]
  12. Spedding M. Direct inhibitory effects of some 'calcium-antagonists' and trifluoperazine on the contractile proteins in smooth muscle. Br J Pharmacol. 1983 May;79(1):225–231. doi: 10.1111/j.1476-5381.1983.tb10516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Williams R. G., Broadley K. J. Responses mediated via beta 1, but not beta 2-adrenoceptors, exhibit hypothermia-induced supersensitivity. Life Sci. 1982 Dec 27;31(26):2977–2983. doi: 10.1016/0024-3205(82)90064-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES